TEK and renal cell carcinoma: GSEA plots demonstrated significant enrichment of the “G2M checkpoint” and “MYC target pathways” in the high TEK expression group (Supplementary Figure S3A), linking TEK to cell cycle control and oncogenic transcriptional regulation, supporting its role as a tumor suppressor in RCC.